Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study

AIMS/INTRODUCTION: Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long‐term treatments are available. METHODS: This was an investigator‐initiated multicenter prospective intervention study in which ipragliflozin (50 mg) was administered once daily, and g...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuba, Ikuro, Kawata, Takehiro, Iemitsu, Kotaro, Asakura, Taro, Amemiya, Hikaru, Ishikawa, Masashi, Ito, Syogo, Kaneshiro, Mizuki, Kanamori, Akira, Kubota, Akira, Shinoda, Kazuaki, Takai, Masahiko, Takuma, Tetsuo, Takihata, Masahiro, Takeda, Hiroshi, Tanaka, Keiji, Matsuzawa, Yoko, Machimura, Hideo, Minagawa, Fuyuki, Minami, Nobuaki, Mokubo, Atsuko, Miyakawa, Masaaki, Terauchi, Yasuo, Tanaka, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477528/
https://www.ncbi.nlm.nih.gov/pubmed/32149469
http://dx.doi.org/10.1111/jdi.13248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477528/
https://www.ncbi.nlm.nih.gov/pubmed/32149469
http://dx.doi.org/10.1111/jdi.13248

Ejemplares similares